National Survey on Coronary Patients and Heart Failure Performed in 2 Patient Groups

The purpose of this observational study is to compare frequency of attainment control goals through the more represented cardiovascular factor risk, dyslipidemia, among coronary patients with or without heart failure in cardiology consulting.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronary Patients Cardiovascular Diseases Dyslipidemias Heart Diseases Heart Failure Lipid Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Abbeville, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patient with coronary disease diagnosed since at least 1 year
Echocardiography done less than 1 year ago
patient with or without documented heart failure

Exclusion criteria

None

Treatment and study plan

Primary outcomes

Frequency of attainment control goals through the more represented cardiovascular factor risk, dyslipidemia, among coronary patients with or without heart failure in cardiology consulting.

Time frame: Once

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Comparison and Description of Coronary Patients Management With or Without Heart Failure in Cardiology Consulting

Acronym: COMPAR

Important dates

Study start: 2008
Study completion: 2009
First posted: Jun 18, 2008
Registry last updated: Aug 6, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed